StockNews.com assumed coverage on shares of Arcadia Biosciences (NASDAQ:RKDA – Free Report) in a report published on Saturday. The firm issued a sell rating on the basic materials company’s stock.
Separately, HC Wainwright reissued a buy rating and set a $6.00 price target on shares of Arcadia Biosciences in a research report on Wednesday, August 21st.
View Our Latest Stock Report on RKDA
Arcadia Biosciences Trading Down 0.4 %
Arcadia Biosciences (NASDAQ:RKDA – Get Free Report) last announced its quarterly earnings results on Tuesday, August 13th. The basic materials company reported $0.78 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.27 by ($0.49). The firm had revenue of $1.31 million during the quarter, compared to the consensus estimate of $0.95 million. Arcadia Biosciences had a negative return on equity of 57.51% and a negative net margin of 127.29%. During the same quarter in the previous year, the firm earned ($2.64) EPS. On average, equities research analysts predict that Arcadia Biosciences will post -1.7 EPS for the current year.
Arcadia Biosciences Company Profile
Arcadia Biosciences, Inc produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring.
Further Reading
- Five stocks we like better than Arcadia Biosciences
- The 3 Best Fintech Stocks to Buy Now
- CarMax’s Impressive Rally: What Investors Should Watch Next
- How to Invest in Small Cap Stocks
- MarketBeat Week in Review – 9/23 – 9/27
- Upcoming IPO Stock Lockup Period, Explained
- Wake Up to This Biotech Stock That Still Has Big Potential Upside
Receive News & Ratings for Arcadia Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arcadia Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.